Literature DB >> 9618145

Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.

M K Majumdar1, M A Thiede, J D Mosca, M Moorman, S L Gerson.   

Abstract

Mesenchymal stem cells (MSCs) are a population of pluripotent cells within the bone marrow microenvironment defined by their ability to differentiate into cells of the osteogenic, chondrogenic, tendonogenic, adipogenic, and myogenic lineages. We have developed methodologies to isolate and culture-expand MSCs from human bone marrow, and in this study, we examined the MSC's role as a stromal cell precursor capable of supporting hematopoietic differentiation in vitro. We examined the morphology, phenotype, and in vitro function of cultures of MSCs and traditional marrow-derived stromal cells (MDSCs) from the same marrow sample. MSCs are morphologically distinct from MDSC cultures, and flow cytometric analyses show that MSCs are a homogeneous cell population devoid of hematopoietic cells. RT-PCR analysis of cytokine and growth factor mRNA in MSCs and MDSCs revealed a very similar pattern of mRNAs including IL-6, -7, -8, -11, -12, -14, and -15, M-CSF, Flt-3 ligand, and SCF. Steady-state levels of IL-11 and IL-12 mRNA were found to be greater in MSCs. Addition of IL-1alpha induced steady-state levels of G-CSF and GM-CSF mRNA in both cell preparations. In contrast, IL-1alpha induced IL-1alpha and LIF mRNA levels only in MSCs, further emphasizing phenotypic differences between MSCs and MDSCs. In long-term bone marrow culture (LTBMC), MSCs maintained the hematopoietic differentiation of CD34+ hematopoietic progenitor cells. Together, these data suggest that MSCs represent an important cellular component of the bone marrow microenvironment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618145     DOI: 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  175 in total

Review 1.  Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.

Authors:  Eva Syková; Pavla Jendelová; Lucia Urdzíková; Petr Lesný; Ales Hejcl
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

2.  Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1.

Authors:  M Emura; A Ochiai; M Horino; W Arndt; K Kamino; S Hirohashi
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-02       Impact factor: 2.416

3.  Xeno-free proliferation of human bone marrow mesenchymal stem cells.

Authors:  Hiroto Miwa; Yoshiki Hashimoto; Keiji Tensho; Shigeyuki Wakitani; Mutsumi Takagi
Journal:  Cytotechnology       Date:  2011-10-15       Impact factor: 2.058

4.  Polarization and migration of hematopoietic stem and progenitor cells rely on the RhoA/ROCK I pathway and an active reorganization of the microtubule network.

Authors:  Ana-Violeta Fonseca; Daniel Freund; Martin Bornhäuser; Denis Corbeil
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

5.  Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential.

Authors:  Sergey V Smirnov; Ryhor Harbacheuski; Anita Lewis-Antes; Hua Zhu; Pranela Rameshwar; Sergei V Kotenko
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

6.  Streptococcus gordonii promotes rapid differentiation of monocytes into dendritic cells through interaction with the sialic acid-binding adhesin.

Authors:  Yumiko Urano-Tashiro; Ayako Yajima; Yukihiro Takahashi; Kiyoshi Konishi
Journal:  Odontology       Date:  2011-10-18       Impact factor: 2.634

7.  Neural differentiation potential of peripheral blood- and bone-marrow-derived precursor cells.

Authors:  Sangnyon Kim; Osamu Honmou; Kazunori Kato; Tadashi Nonaka; Kiyohiro Houkin; Hirufumi Hamada; Jeffery D Kocsis
Journal:  Brain Res       Date:  2006-10-24       Impact factor: 3.252

8.  Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation.

Authors:  Nak Gyun Chung; Dae Chul Jeong; Soo Jeong Park; Byung Ock Choi; Bin Cho; Hack Ki Kim; Chung Sik Chun; Jong Ho Won; Chi Wha Han
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

Review 9.  Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions.

Authors:  Jeffery J Auletta; Kenneth R Cooke; Luis A Solchaga; Robert J Deans; Wouter van't Hof
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-16       Impact factor: 5.742

10.  Cytosine arabinoside reduces the numbers of granulocyte macrophage colony forming cells (GM-CFC) and high proliferative potential colony forming cells (HPP-CFC) in vivo in mice.

Authors:  Stanley Teleka; Alexander Chijuwa; Edward Senga; John E Chisi
Journal:  Malawi Med J       Date:  2011-12       Impact factor: 0.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.